205 related articles for article (PubMed ID: 25001308)
21. Design and synthesis of 3-isoxazolidone derivatives as new Chlamydia trachomatis inhibitors.
Abdelsayed S; Ha Duong NT; Hai J; Hémadi M; El Hage Chahine JM; Verbeke P; Serradji N
Bioorg Med Chem Lett; 2014 Aug; 24(16):3854-60. PubMed ID: 25027937
[TBL] [Abstract][Full Text] [Related]
22.
Seleem MA; Wood NA; Brinkworth AJ; Manam S; Carabeo RA; Murthy AK; Ouellette SP; Conda-Sheridan M
ACS Infect Dis; 2022 Jan; 8(1):227-241. PubMed ID: 34935346
[No Abstract] [Full Text] [Related]
23. An optimized, fast-to-perform mouse lung infection model with the human pathogen Chlamydia trachomatis for in vivo screening of antibiotics, vaccine candidates and modified host-pathogen interactions.
Dutow P; Wask L; Bothe M; Fehlhaber B; Laudeley R; Rheinheimer C; Yang Z; Zhong G; Glage S; Klos A
Pathog Dis; 2016 Mar; 74(2):. PubMed ID: 26676260
[TBL] [Abstract][Full Text] [Related]
24. New treatments for Chlamydia trachomatis.
Jones RB
Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 2):1789-93. PubMed ID: 2039033
[TBL] [Abstract][Full Text] [Related]
25. Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles.
Toti US; Guru BR; Hali M; McPharlin CM; Wykes SM; Panyam J; Whittum-Hudson JA
Biomaterials; 2011 Sep; 32(27):6606-13. PubMed ID: 21652065
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro.
Ikeda-Dantsuji Y; Feril LB; Tachibana K; Ogawa K; Endo H; Harada Y; Suzuki R; Maruyama K
Ultrason Sonochem; 2011 Jan; 18(1):425-30. PubMed ID: 20728399
[TBL] [Abstract][Full Text] [Related]
27. Rhein inhibits
Yu X; Xu Q; Chen W; Mai Z; Mo L; Su X; Ou J; Lan Y; Zheng H; Xue Y
Front Public Health; 2022; 10():1002029. PubMed ID: 36238249
[TBL] [Abstract][Full Text] [Related]
28. Assessing a potential role of host Pannexin 1 during Chlamydia trachomatis infection.
McKuen MJ; Dahl G; Fields KA
PLoS One; 2013; 8(5):e63732. PubMed ID: 23700432
[TBL] [Abstract][Full Text] [Related]
29. Host and Bacterial Glycolysis during
Ende RJ; Derré I
Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32900818
[TBL] [Abstract][Full Text] [Related]
30. The effect of antibiotic treatment on active trachoma and ocular Chlamydia trachomatis infection.
Mabey D; Solomon A
Expert Rev Anti Infect Ther; 2003 Aug; 1(2):209-16. PubMed ID: 15482115
[TBL] [Abstract][Full Text] [Related]
31. Targeted Delivery of Amoxicillin to C. trachomatis by the Transferrin Iron Acquisition Pathway.
Hai J; Serradji N; Mouton L; Redeker V; Cornu D; El Hage Chahine JM; Verbeke P; Hémadi M
PLoS One; 2016; 11(2):e0150031. PubMed ID: 26919720
[TBL] [Abstract][Full Text] [Related]
32. Chlamydia trachomatis-infected human cells convert ceramide to sphingomyelin without sphingomyelin synthases 1 and 2.
Tachida Y; Kumagai K; Sakai S; Ando S; Yamaji T; Hanada K
FEBS Lett; 2020 Feb; 594(3):519-529. PubMed ID: 31596951
[TBL] [Abstract][Full Text] [Related]
33. Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion.
Ur-Rehman T; Slepenkin A; Chu H; Blomgren A; Dahlgren MK; Zetterström CE; Peterson EM; Elofsson M; Gylfe A
J Antibiot (Tokyo); 2012 Aug; 65(8):397-404. PubMed ID: 22669447
[TBL] [Abstract][Full Text] [Related]
34. Combination with antimicrobial peptide lyses improves loop-mediated isothermal amplification based method for Chlamydia trachomatis detection directly in urine sample.
Jevtuševskaja J; Uusna J; Andresen L; Krõlov K; Laanpere M; Grellier T; Tulp I; Langel Ü
BMC Infect Dis; 2016 Jul; 16():329. PubMed ID: 27412444
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Chlamydial infections: 2014 update.
Kohlhoff SA; Hammerschlag MR
Expert Opin Pharmacother; 2015 Feb; 16(2):205-12. PubMed ID: 25579069
[TBL] [Abstract][Full Text] [Related]
36. [Determining antimicrobial resistance to Chlamydia trachomatis and applying present findings in daily practice].
Sternak SL; Skerk V
Med Glas (Zenica); 2010 Feb; 7(1):26-31. PubMed ID: 20387721
[TBL] [Abstract][Full Text] [Related]
37. CtHtrA: the lynchpin of the chlamydial surface and a promising therapeutic target.
Marsh JW; Ong VA; Lott WB; Timms P; Tyndall JD; Huston WM
Future Microbiol; 2017 Jul; 12():817-829. PubMed ID: 28593794
[TBL] [Abstract][Full Text] [Related]
38. Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis.
Sweet RL; Schachter J; Robbie MO
JAMA; 1983 Nov; 250(19):2641-5. PubMed ID: 6632163
[TBL] [Abstract][Full Text] [Related]
39. Golgi fragmentation and sphingomyelin transport to Chlamydia trachomatis during penicillin-induced persistence do not depend on the cytosolic presence of the chlamydial protease CPAF.
Dille S; Herbst K; Volceanov L; Nölke T; Kretz O; Häcker G
PLoS One; 2014; 9(7):e103220. PubMed ID: 25068694
[TBL] [Abstract][Full Text] [Related]
40. Resistance to a novel antichlamydial compound is mediated through mutations in Chlamydia trachomatis secY.
Sandoz KM; Eriksen SG; Jeffrey BM; Suchland RJ; Putman TE; Hruby DE; Jordan R; Rockey DD
Antimicrob Agents Chemother; 2012 Aug; 56(8):4296-302. PubMed ID: 22644029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
